GO:0000112 nucleotide-excision repair factor 3 complex

The nucleotide-excision repair factor 3 complex (NEF3; GO:0000112) is a multisubunit cellular component that executes the dual-incision step of nucleotide-excision repair (NER), the versatile DNA repair pathway that removes bulky helix-distorting lesions such as ultraviolet-induced cyclobutane pyrimidine dimers and 6-4 photoproducts. In the yeast Saccharomyces cerevisiae, NEF3 is defined as Rad2p together with the core TFIIH-Ssl2p complex, in which core TFIIH is composed of Rad3p, Tfb1p, Tfb2p, Ssl1p, Tfb4p and Tfb5p, and Ssl2p (Rad25p) contributes the DNA helicase activity required for opening DNA around the lesion. The complex therefore couples lesion verification by TFIIH with the endodeoxyribonuclease activity of Rad2p that nicks the damaged strand on both sides of the adduct. Because NER is the principal defense against UV- and chemical-induced DNA damage, the composition and regulation of NEF3 are of broad biomedical interest. Mutations affecting TFIIH subunits and downstream NER factors underlie a spectrum of human disorders with overlapping features, including xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy, which differ in photosensitivity, neurodegeneration and developmental abnormalities. Recent structural work has revealed how lesion recognition by XPC, TFIIH and XPA positions the damaged strand for incision, and how accessory factors such as STK19 participate in transcription-coupled repair, providing a mechanistic framework for understanding NEF3 function. For researchers, GO:0000112 provides a precise annotation target for interrogating the assembly, catalytic mechanism and disease relevance of the NER incision machinery. This article synthesizes the QuickGO definition with verified literature to outline the composition, mechanism, regulation and experimental models available to study NEF3, and to highlight how CRISPR-based cell models can be used to test causal roles of its subunits.

GO:0000112, nucleotide-excision repair factor 3 complex (synonym NEF3 complex), is a cellular component annotation describing one of several protein complexes dedicated to nucleotide-excision repair. According to the QuickGO definition, the complex possesses endodeoxynuclease and DNA helicase activities. In S. cerevisiae, it is composed of Rad2p and the core TFIIH-Ssl2p complex, where core TFIIH is composed of Rad3p, Tfb1p, Tfb2p, Ssl1p, Tfb4p and Tfb5p, and Ssl2p is also known as Rad25p.

The nucleotide-excision repair factor 3 complex is important because it performs the decisive dual-incision event of NER, without which bulky DNA lesions persist and block transcription and replication, driving mutagenesis, cell death and disease. Its TFIIH-associated helicase and Rad2p nuclease activities are conserved features of the repair machinery, and structural studies continue to refine how lesion recognition by XPC, TFIIH and XPA is coupled to incision. Clinically, inherited defects in NER factor complexes produce heterogeneous disorders with photosensitivity, cancer predisposition and neurological decline, making NEF3 a focal point for mechanistic and translational research. Emerging work on transcription-coupled repair regulators such as STK19 further underscores how the NEF3-centered incision machinery is integrated with transcription and genome maintenance.

The following genes and proteins represent the verified components and interacting factors of the nucleotide-excision repair factor 3 complex and its associated NER machinery.

Regulation of NEF3-dependent repair is integrated with transcription and DNA damage signaling. Transcription-coupled repair, which preferentially removes lesions from actively transcribed strands, involves factors such as STK19 that have recently been shown to unlock transcription-coupled DNA repair. The PPARγ-p53 vasculoregenerative program illustrates how p53-centered stress responses can be modulated in disease contexts, providing a conceptual parallel for how DNA damage responses are regulated. In clinical genomics, rapid identification of primary atopic disorders using landmark-guided sequencing highlights the broader trend of using genomic approaches to define regulatory and pathway defects. However, direct post-translational regulation of NEF3 subunits is not detailed in the verified citations and should be described generically.

Heterogeneity and overlaps in nucleotide-excision repair disorders arise from defects in NER factors, producing conditions such as xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy with varying photosensitivity, neurodegeneration and developmental features. Because NEF3 provides the incision activity of NER, its dysfunction is mechanistically linked to these phenotypes.

Failure to remove UV-induced lesions leads to mutagenesis and cancer predisposition, a hallmark of xeroderma pigmentosum. The dual-incision activity of NEF3 is central to preventing such lesions from persisting.

Transcription-coupled repair defects are associated with severe neurological phenotypes in Cockayne syndrome. Emerging understanding of STK19 in transcription-coupled DNA repair provides new mechanistic insight into how incision is coupled to transcription.

Measuring dual-incision and repair synthesis after UV or chemical damage is the primary way to assess NEF3 function, using established NER assays in yeast and human cells.

Structural studies of XPC, TFIIH and XPA bound to damaged DNA reveal how lesion recognition is coupled to incision and inform models of NEF3 architecture.

Clinical landmark-guided genomic sequencing can identify pathogenic variants in NER genes, supporting diagnosis of NER disorders.

p53-responsive and stress programs can be monitored to contextualize DNA damage responses, as illustrated by PPARγ-p53 vasculoregenerative studies.

Researchers studying nucleotide-excision repair factor 3 complex-related genes often need to determine whether a candidate gene is causally involved in repair, transcription-coupled processes or disease phenotypes. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses with publication-grade rigor.

GO:0000112, the nucleotide-excision repair factor 3 complex, is a conserved NER machine that couples TFIIH helicase activity with Rad2p endodeoxynuclease activity to execute the dual-incision step of DNA repair. Its composition in S. cerevisiae and its relationship to human TFIIH and NER factors make it a powerful model for understanding lesion recognition, incision and disease. Defects in NER complexes cause heterogeneous disorders with photosensitivity, cancer predisposition and neurodegeneration, underscoring the clinical importance of this complex. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with screening and bioinformatics, provide a rigorous path to dissect NEF3 subunit functions and their roles in disease. EDITGENE supports these efforts with tailored cell model and screening services for NER research.